Extraordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 17th October 2022
Due to the IPO of AIM VACCINE CO LTD., the company will be added via an extraordinary rebalance effective open 17.10.2022.
In the extraordinary rebalancing the following index composition will be implemented effective open 17.10.2022:
| 3SBIO INC |
| AIM VACCINE CO LTD |
| AKESO INC |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD |
| ANGELALIGN TECHNOLOGY INC |
| CANSINO BIOLOGICS INC |
| CARSGEN THERAPEUTICS HOLDING |
| CHINA MEDICAL SYSTEM HOLDINGS LTD |
| CLOUDR GROUP LTD |
| CSPC PHARMACEUTICAL GROUP LTD |
| GENSCRIPT BIOTECH CORP |
| GRAND PHARMACEUTICAL GROUP LTD |
| GUSHENGTANG HOLDINGS LTD |
| HANSOH PHARMACEUTICAL GROUP CO |
| INNOCARE PHARMA LTD |
| INNOVENT BIOLOGICS INC |
| JD HEALTH INTERNATIONAL INC |
| JOINN LABORATORIES CHINA C-H |
| KEYMED BIOSCIENCES INC |
| LIFETECH SCIENTIFIC CORP |
| LUYE PHARMA GROUP LTD |
| MICROPORT NEUROTECH LTD |
| MICROPORT SCIENTIFIC CORP |
| PING AN HEALTHCARE AND TECHNOL |
| REMEGEN CO LTD-H |
| SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD |
| SHANGHAI BIO-HEART BIOLOGI-H |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD |
| SHANGHAI MICROPORT MEDBOT GR |
| SIMCERE PHARMACEUTICAL GROUP |
| SINO BIOPHARMACEUTICAL LTD ORD |
| WUXI APPTEC CO LTD |
| WUXI BIOLOGICS CAYMAN INC |
| ZAI LAB LTD |